Pooled Systemic Efficacy and Safety Data from the Pivotal Phase II Studies (NP28673 and NP28761) of Alectinib in ALK -positive Non-Small Cell Lung Cancer
収録刊行物
-
- Journal of Thoracic Oncology
-
Journal of Thoracic Oncology 12 (10), 1552-1560, 2017-10
Elsevier BV